Journal
JOURNAL OF PARKINSONS DISEASE
Volume 7, Issue 1, Pages 89-94Publisher
IOS PRESS
DOI: 10.3233/JPD-161031
Keywords
Parkinson's disease; deep brain stimulation; surveys; patient preference
Categories
Funding
- Michael J. Fox Foundation for Parkinson's Research
Ask authors/readers for more resources
The FDA has approved a multicenter, double-blind, Phase III, pivotal trial testing deep brain stimulation (DBS) in 280 people with very early stage Parkinson's disease (PD; IDE#G050016). In partnership with The Michael J. Fox Foundation for Parkinson's Research, we conducted a survey to investigate motivating factors, barriers, and gender differences among potentially eligible patients for participation in a trial testing DBS in early PD compared to standard medical treatment. The majority of survey respondents (72%) indicated they would consider learning more about participating. Early PD patients are therefore likely to consider enrolling in trials of invasive therapies that may slow symptom progression and help future patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available